Jyss Bio

Zhejiang Jyss Bio-Engineering Co., Ltd. (Jyss Bio) is a high-tech enterprise founded in 2014 that localizes single-use bioreactors and assemblies for the biopharmaceutical industry in China. The company provides comprehensive technological solutions for the entire biopharmaceutical process, from research and development to industrialization. Its offerings cater to pharmaceutical production and R&D institutions involved with antibody drugs, vaccines, gene therapy, and cell therapy.

The company's product portfolio is centered around its core single-use bioreactors, which feature a patented, non-bubbling oxygen transfer mechanism designed for high efficiency and low shear force, enabling high-density cell cultivation. Beyond bioreactors, Jyss Bio develops and manufactures a wide array of single-use consumables and equipment for the entire bioprocess workflow. This includes products for cell culture, fluid management, purification, and filtration. Specific products include various bioreactor models (stirred, torrent, wave-mixed), magnetic mixing systems, sterile tube welders and sealers, chromatography systems, and single-use storage, mixing, and sampling bags.

Founded in Hangzhou, China, Jyss Bio operates multiple facilities, including GMP-compliant production workshops for consumables and bioreactors in Hangzhou and Huzhou, and a manufacturing base in Shanghai for downstream equipment. The company has received significant venture capital backing, completing Series A, B, and B+ funding rounds in 2021 and 2022 to expand production capacity and accelerate R&D. Key investors include Huatai International, CICC Capital, and Sinovac. As part of its growth, Jyss Bio has expanded its product lines into downstream purification with chromatography and ultrafiltration systems to provide integrated upstream and downstream solutions. The company was recognized for its contribution during the COVID-19 pandemic by CanSino Bio and has received industry awards such as the "2021 Best IVD and Life Science Enterprise Award".

Keywords: single-use bioreactors, bioprocessing solutions, biopharmaceutical consumables, cell culture technology, fluid management systems, chromatography systems, ultrafiltration systems, gene therapy, cell therapy, vaccine production, antibody drugs, disposable bioprocess, sterile consumables, biopharma manufacturing, process development, upstream processing, downstream purification, GMP manufacturing, single-use assemblies, liquid handling